Trial
NCT07025512
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
M.D. Anderson Cancer Center
Collaborators
Novartis
Condition
Metastatic Castration Resistant Prostate Cancer
Intervention
177Lu-PSMA-617
Why stopped
PI requested
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08